Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

But between shortages, high out of pocket costs and the need for weekly injections, the medication is not suited for everyone ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Rising numbers of people are needing hospital treatment for side effects from weight loss injections and it may be affecting ...

Sheila Hogan was a size 22 and a yo-yo dieter, but she now managed to lose 5st after she could barely climb the stairs and ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.